References
- Van den Berghe H, Vermaelen K, Mecucci C, . The 5q- anomaly. Cancer Genet Cytogenet 1985;17:189–255.
- Haase D. Cytogenetic features in myelodysplastic syndromes. Ann Hematol 2008;87:515–526.
- Giagounidis AA, Germing U, Aul C. Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies. Clin Cancer Res 2006;12:5–10.
- Herry A, Douet-Guilbert N, Morel F, . Evaluation of chromosome 5 aberrations in complex karyotypes of patients with myeloid disorders reveals their contribution to dicentric and tricentric chromosomes, resulting in the loss of critical 5q regions. Cancer Genet Cytogenet 2007;175:125–131.
- Douet-Guilbert N, Basinko A, Eveillard JR, . Three rearrangements of chromosome 5 in a patient with myelodysplastic syndrome: an atypical deletion 5q, a complex intrachromosomal rearrangement of chromosome 5, and a paracentric inversion of chromosome 5. Cancer Genet Cytogenet 2010;203:303–308.
- De Braekeleer E, Douet-Guilbert N, Basinko A, . Using bacterial artificial chromosomes in leukemia research: the experience at the university cytogenetics laboratory in Brest, France. J Biomed Biotechnol 2011;2011:329–471.